| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.68 |
—
—
—
|
| 2025 | 1.68 |
—
—
—
—
|
| 2024 | 1.68 |
—
—
—
—
|
| 2023 | 1.68 |
—
—
—
—
|
| 2022 | 1.60 |
—
—
—
—
|
| 2021 | 1.41 |
—
—
—
—
|
| 2020 | 1.32 |
—
—
—
—
|
| 2019 | 1.20 |
—
—
—
—
|
| 2018 | 1.10 |
—
—
—
—
|
| 2017 | 0.92 |
—
—
—
—
|
| 2016 | 0.80 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 104.45 | 220.21 | 103.24 | 104.85 |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 4,175.93 | 4,310.79 | 5,038.14 | 5,077.60 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 4,597.36 | 4,633.17 | 5,537.78 | 5,555.10 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 5,175.11 | 5,229.58 | 6,215.51 | 6,162.39 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 90.35 | 93.46 | — | — |
—
|
| ’25 | 89.59 | 92.39 | 95.02 | 96.18 |
373.18
|
| ’24 | 70.51 | 72.81 | 75.13 | 75.66 |
294.10
|
| ’23 | 62.59 | 66.17 | 62.74 | 65.78 |
257.28
|
| ’22 | 48.68 | 51.17 | 54.54 | 59.10 |
213.49
|
| ’21 | 50.60 | 47.59 | 48.48 | 51.55 |
198.22
|
| ’20 | 51.62 | 51.24 | 51.36 | 53.47 |
207.69
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 20.01 | 31.16 | — | — |
—
|
| ’25 | 1.03 | 6.03 | 36.10 | 20.75 |
63.91
|
| ’24 | 17.76 | 14.49 | (14.50) | 43.19 |
60.93
|
| ’23 | 14.52 | 17.13 | 47.16 | (11.30) |
67.51
|
| ’22 | 42.75 | 26.77 | 15.20 | 20.47 |
105.18
|
| ’21 | 62.06 | 22.45 | 27.16 | 31.05 |
142.72
|
| ’20 | (32.99) | 13.51 | 13.56 | 24.16 |
18.23
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 18.23 | 29.91 | — | — |
—
|
| ’25 | (0.73) | 4.55 | 38.59 | 18.98 |
61.39
|
| ’24 | 17.21 | 13.20 | (16.21) | 41.16 |
55.36
|
| ’23 | 14.02 | 16.60 | 46.46 | (12.19) |
64.89
|
| ’22 | 42.36 | 26.21 | 15.27 | 19.63 |
103.47
|
| ’21 | 61.74 | 22.92 | 25.46 | 30.75 |
140.86
|
| ’20 | (34.28) | 12.53 | 13.23 | 23.83 |
15.30
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.29 | 1.35 | — | — |
—
|
| ’25 | 0.43 | 0.83 | 1.25 | 1.33 |
3.84
|
| ’24 | 0.91 | 0.81 | 0.90 | 1.00 |
3.62
|
| ’23 | 0.87 | 0.85 | 0.67 | 0.58 |
2.97
|
| ’22 | 1.13 | 1.02 | 0.97 | 1.05 |
4.17
|
| ’21 | 1.31 | 1.21 | 0.97 | 1.11 |
4.60
|
| ’20 | 0.89 | 0.73 | 1.11 | 1.22 |
3.95
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.35 | 26.52 | 28.62 | 34.53 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 52.16 | 42.95 | 50.07 | 46.80 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 630 | 600 | 586 | 683 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.34 | 0.43 | 0.50 | 0.55 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 213.49 | 257.28 | 294.10 | 373.18 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 88.25% | 63.47% | 60.18% | 68.54% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 77.05 | 53.84 | 65.46 | 78.66 | — | — | — |
EBT
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.09% | 20.93% | 22.26% | 21.08% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.44 | 43.38 | 53.00 | 65.16 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.95 | 6.28 | 5.65 | 12.88 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.58 | 17.67 | 20.17 | 22.08 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 4.18 | 2.98 | 3.63 | 3.86 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.18 | 4.64 | 4.18 | 3.78 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.12) | (0.18) | (0.38) | (0.15) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.07 | 4.46 | 3.80 | 3.63 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.82 | 33.99 | 36.44 | 41.22 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.64 | 14.56 | 14.58 | 16.90 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.01 | 12.73 | 11.74 | 11.27 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.87 | 2.14 | 2.12 | 1.96 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.36 | 1.11 | 1.17 | 1.05 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.96 | 3.74 | 3.13 | 3.12 | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.16 | 14.83 | 16.61 | 18.97 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 105.18 | 67.51 | 60.93 | 63.91 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.72) | (2.62) | (5.58) | (2.52) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 103.47 | 64.89 | 55.36 | 61.39 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,118.20) | (999.18) | (918.79) | (1,177.37) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 311.33 | 44.33 | 44.33 | 62.52 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 231.91 | (60.12) | (175.87) | (40.72) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 451.28 | 495.06 | 531.23 | 696.56 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.10% | 0.76% | 0.92% | 1.02% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.05% | 7.74% | 11.72% | 8.38% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.35% | 9.16% | 10.33% | 10.61% | — | — | — |
ROE
|
Camden National Corporation (CAC), a steady regional bank serving Maine, has delivered resilient growth amid economic challenges, with revenue surging 74% from $169 million in 2016 to $294 million in 2024, driven by net interest income and efficiency gains—revenue per employee doubled to $502,000 despite a slight headcount dip. Net income rose 22% to $53 million last year, bolstered by a pristine balance sheet: debt plunged 93% to $44 million, free cash flow supports dividends and buybacks, and book value per share climbed 43% to $36.4. ROE consistently outperforms peers at 10-12.6%, underscoring conservative capital deployment in a sector prone to volatility.
Stock performance tracks fundamentals closely, with a 10% CAGR in yearly highs and attractive valuations—P/E at 11.7x, P/B at 1.2x—trading at a discount to historical norms and peers. EPS grew 40% cumulatively to $3.63, with ROIC rebounding to 11.7%, though margins face pressures from funding costs and regional economic softness in tourism and manufacturing.
Analysts forecast robust recovery: EPS potentially up 49% to $5.95 by 2027 amid NIM expansion, implying 6-8% upside and 65% odds of 15%+ returns, backed by quant models. Yet risks loom—recessionary credit losses, deposit outflows, or prolonged high rates—with CAC’s low leverage and deposit beta offering buffers. A high-conviction hold for risk-averse investors, but monitor Q1 2026 earnings for confirmation.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.